OFF-THE-SHELF, ENGINEERED IPSC-DERIVED NK CELLS MEDIATE POTENT CYTOTOXIC ACTIVITY AGAINST PRIMARY GLIOBLASTOMA CELLS AND PROMOTE DURABLE LONG-TERM SURVIVAL IN VIVOJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62021-11-100OA
IPSC-DERIVED NK CELLS MEDIATE ROBUST ANTI-TUMOR ACTIVITY AGAINST GLIOBLASTOMAJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62020-12-101OAAI
TARGETING PAN-TUMOR ASSOCIATED ANTIGEN B7H3 VIA COMBINATION OF TRI-SPECIFIC KILLER ENGAGER AND OFF-THE-SHELF NK CELL THERAPY ENHANCES SPECIFICITY AND FUNCTION AGAINST A BROAD RANGE OF SOLID TUMORSJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62020-11-092PREAI